Search CCR News:
Below are links to NCI press releases that highlight new advances in basic, clinical, and translational science at the Center for Cancer Research.
Investigational targeted drug induces responses in aggressive lymphomas
(Posted: 4/10/2012) - Preliminary results from clinical trials in a subtype of lymphoma show that for a number of patients whose disease was not cured by other treatments, the drug ibrutinib can provide significant anti-cancer responses with modest side effects.
(Posted: 4/10/2012) - Patients with an AIDS-associated cancer, Kaposi's sarcoma (KS), showed improvement after receiving the combination of bevacizumab, a cancer drug that blocks the growth of new blood vessels, and highly active antiretroviral therapy (HAART).
(Posted: 1/31/2012) - A new type of lab has been created to utilize near-atomic resolution microscopy and other structural biology technologies to help accelerate important medical discoveries relating to global health challenges, such as cancer and HIV/AIDS. The Living Lab Structural Biology Center was formed through a cooperative research and development agreement between the National Institutes of Health and FEI, Hillsboro, Ore., a scientific instruments company.
A service of the National Cancer Institute
